Literature DB >> 31798213

Hepatic Microwave Ablation in Challenging Locations.

Amanda R Smolock1, Colette Shaw1.   

Abstract

In recent years, there has been increased utilization of microwave ablation (MWA) in the treatment of soft tissue tumors. MWA has several theoretical advantages over radiofrequency ablation (RFA) by achieving a more rapid and sustained heating of tissues, increased efficacy in tissues with poor thermal conductivity, and less susceptibility to heat sink effect. While its greater power output has led to appropriate caution when applying this energy to soft tissue tumors, many commonly held beliefs regarding contraindications to MWA are unsupported by data and have been passed along based on experience with RFA. The goal of this article is to review the use of MWA in challenging clinical situations along with the existing evidence for its use. © Thieme Medical Publishers.

Entities:  

Keywords:  contraindications; liver transplant; microwave ablation; tumor ablation

Year:  2019        PMID: 31798213      PMCID: PMC6887525          DOI: 10.1055/s-0039-1697003

Source DB:  PubMed          Journal:  Semin Intervent Radiol        ISSN: 0739-9529            Impact factor:   1.513


  27 in total

1.  Diaphragmatic perforation and hernia after hepatic radiofrequency ablation.

Authors:  Masahiko Koda; Masaru Ueki; Naoto Maeda; Yoshikazu Murawaki
Journal:  AJR Am J Roentgenol       Date:  2003-06       Impact factor: 3.959

2.  Safety and Efficacy of Percutaneous Microwave Hepatic Ablation Near the Heart.

Authors:  George A Carberry; Amanda R Smolock; Mircea Cristescu; Shane A Wells; Timothy J Ziemlewicz; Meghan G Lubner; J Louis Hinshaw; Christopher L Brace; Fred T Lee
Journal:  J Vasc Interv Radiol       Date:  2017-02-10       Impact factor: 3.464

3.  Microwave liver ablation: influence of hepatic vein size on heat-sink effect in a porcine model.

Authors:  Nam C Yu; Steven S Raman; Young Jun Kim; Charles Lassman; Xinlian Chang; David S K Lu
Journal:  J Vasc Interv Radiol       Date:  2008-05-27       Impact factor: 3.464

4.  CT-Guided Percutaneous Microwave Ablation of Tumors in the Hepatic Dome: Assessment of Efficacy and Safety.

Authors:  Nazanin H Asvadi; Arash Anvari; Raul N Uppot; Ashraf Thabet; Andrew X Zhu; Ronald S Arellano
Journal:  J Vasc Interv Radiol       Date:  2016-02-28       Impact factor: 3.464

5.  Diagnosis, Staging, and Management of Hepatocellular Carcinoma: 2018 Practice Guidance by the American Association for the Study of Liver Diseases.

Authors:  Jorge A Marrero; Laura M Kulik; Claude B Sirlin; Andrew X Zhu; Richard S Finn; Michael M Abecassis; Lewis R Roberts; Julie K Heimbach
Journal:  Hepatology       Date:  2018-08       Impact factor: 17.425

Review 6.  Microwave tissue ablation: biophysics, technology, and applications.

Authors:  Christopher L Brace
Journal:  Crit Rev Biomed Eng       Date:  2010

Review 7.  Microwave tumor ablation: mechanism of action, clinical results, and devices.

Authors:  Meghan G Lubner; Christopher L Brace; J Louis Hinshaw; Fred T Lee
Journal:  J Vasc Interv Radiol       Date:  2010-08       Impact factor: 3.464

Review 8.  Microwave ablation of hepatic malignancy.

Authors:  Meghan G Lubner; Christopher L Brace; Tim J Ziemlewicz; J Louis Hinshaw; Fred T Lee
Journal:  Semin Intervent Radiol       Date:  2013-03       Impact factor: 1.513

Review 9.  Radiofrequency and microwave ablation of the liver, lung, kidney, and bone: what are the differences?

Authors:  Christopher L Brace
Journal:  Curr Probl Diagn Radiol       Date:  2009 May-Jun

10.  Quality improvement guidelines for radiofrequency ablation of liver tumours.

Authors:  Laura Crocetti; Thierry de Baere; Riccardo Lencioni
Journal:  Cardiovasc Intervent Radiol       Date:  2010-02       Impact factor: 2.740

View more
  1 in total

1.  Recurrence Outcome in Hepatocellular Carcinoma within Milan Criteria Undergoing Microwave Ablation with or without Transarterial Chemoembolization.

Authors:  Guobin Chen; Hong Chen; Xing Huang; Sisi Cheng; Susu Zheng; Yanfang Wu; Tanghui Zheng; Xiaochun Chen; Xinkun Guo; Zhenzhen Zhang; Xiaoying Xie; Boheng Zhang
Journal:  Medicina (Kaunas)       Date:  2022-07-29       Impact factor: 2.948

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.